… of induction therapy, and demonstrated no difference in OS for the use of two cycles of induction
therapy … failure on the induction arm. However, this would still not establish the benefit of …

… with the goal of maximizing the success of the definitive therapy. Response to induction
therapy … survival in an induction chemotherapy regimen was reported in Cancer.153 That study …

… therapy6 or have advocated the combination of an induction … preservation to date, induction
therapy remains a component of … some of our patients with induction therapy, and continue to …

… advanced untreated but resectable head and neck cancer who would require total
laryngectomy were enrolled on one of two cisplatin-based induction regimens: cisplatinbleomycin-5-…

… Induction therapy of squamous head and neck cancer may not affect overall survival. … for
head and neck cancer was in the recurrent setting which its use was extrapolated to induction. …

… Rooney M, Kish J, Jacobs J, et al: Improved complete response rate and survival in advanced
head and neck cancer after three course induction therapy with 120-hour 5-FU infusion …

Aims Organ preservation, an important goal in the treatment of head and neck squamous
cell carcinoma (HNSCC), may include induction chemotherapy and cisplatin with radiation …

… , is added to induction … therapies more effective in head and neck cancers. Rothenberg
described his work on the mechanisms of resistance to EGFR-targeted therapies in lung cancer …

… Patients with head and neck cancer present numerous challenges to treating physicians. …
and paclitaxel (T) as induction therapy in locally advanced head and neck cancer (LAHNC) …

… and neck cancers, providing opportunity to remove the lesions completely after induction …
, platinum-based chemotherapy and induction therapy. Cetuximab has been approved by the …